Fresh news on business and economy in Israel
Provided by AGPRecent Strategic Actions Expected to Reduce Annualized Cash Burn by Approximately $10 million
Company Executing Three Phase Plan to Maximize Shareholder Value in 2026 and Beyond
Full Year 2026 Guidance Suspended as Strategic Alternatives Process Accelerates
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”), a leader in digital manufacturing solutions, today announced financial results for the first quarter ended March 31, 2026.
First Quarter 2026 Results:
Adjusted EBITDA and Adjusted Gross Margin are non-GAAP financial measures. More information, including a reconciliation of Adjusted EBITDA and Adjusted Gross Margin to the most directly comparable GAAP financial measure can be found below in this press release under “Non-GAAP Financial Measures” and “Reconciliation of US GAAP to Non-GAAP Measures.”
Recent Developments:
Three Phase Strategic Plan Execution: The Company is executing a defined three phase plan to maximize shareholder value in 2026 and beyond, with each phase already underway. Phase One is focused on streamlining operations and reducing cash burn through efficiency initiatives and disciplined cost management. Phase Two is centered on monetization of product lines to simplify the business and strengthen the balance sheet, including the announced sale of its additively manufactured electronics (“AME”) and Fabrica product lines. Phase Three is focused on evaluating strategic alternatives to maximize long term shareholder value and selecting the most compelling path forward, which remains under review.
David Stehlin, Chief Executive Officer, commented, “The three phases of our strategic plan continue to advance in parallel as we accelerate toward increasing shareholder value. We are streamlining operations, monetizing our product lines, and progressing toward potentially selecting a compelling opportunity in the coming months. We have completed the sale of our AME and Fabrica product lines and expect to announce additional product line monetization in the coming weeks. Together, these actions are expected to reduce complexity, lower annualized cash burn, and further strengthen our financial flexibility. Phase 3 is advancing quickly. After receiving numerous inbound opportunities, we have significantly narrowed our focus and are now reviewing a short list of highly attractive strategic alternatives, which we believe have the potential to deliver significant long term value creation in 2026 and beyond.”
Sale of AME and Fabrica Product Lines: On April 6, 2026, Nano Dimension announced the sale of its AME product line and its previously discontinued Fabrica product lines to Inspira Technologies OXY B.H.N. Ltd. for total consideration of up to $12.5 million, including a $2.0 million upfront cash payment and up to $10.5 million in performance-based deferred payments over the next twelve months. This transaction supports the Company’s efforts to streamline operations and lower its cost structure. The Company expects this transaction to reduce annualized cash burn by approximately $10 million.
2026 Financial Guidance Update
Given the Company’s ongoing actions under its defined strategic plan and the potential for additional changes across the business, the Company has suspended its full year 2026 financial guidance at this time.
This decision reflects the range of outcomes currently being implemented and evaluated, including the timing and scope of potential monetization actions that could materially impact future results.
Conference Call Today
Nano Dimension will host a conference call today at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2026.
Participants can pre-register for the conference call in order to receive dial in information via this link: https://dpregister.com/sreg/10208731/103e987e1a7
Participants can also dial-in/connect by following the below:
Listen in via U.S. dial-in: 1-844-695-5517
Listen via international dial-in: 1-412-902-6751
Listen via Israel toll free: 1-80-9212373
Listen via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ZaodVpNh
For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at https://investors.nano-di.com/events-and-presentations.
About Nano Dimension Ltd.
Driven by strong trends in onshoring, national security, and increasing product customization, Nano Dimension Ltd. (Nasdaq: NNDM) delivers advanced Digital Manufacturing technologies to the defense, aerospace, automotive, electronics, and medical devices industries, enabling rapid deployment of high-mix, low-volume production with IP security and sustainable manufacturing practices. For more information, please visit https://www.nano-di.com/.
Non-GAAP Financial Measures
EBITDA is a non-GAAP measure and is defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization. We believe that EBITDA should be useful in evaluating the performance of our business and operations. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.
Adjusted EBITDA and operating expenses are non-GAAP measures and are defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to share-based payments.
Adjusted gross profit, excluding depreciation and amortization, share-based compensation expenses, and step-up amortization from purchase accounting, is a non-GAAP measure. We believe that adjusted gross profit, as described above, should also be useful in evaluating the performance of our business. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.
EBITDA and Adjusted EBITDA, Adjusted gross profit and non-GAAP operating expenses can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.
Nano Dimension does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures due to the inherent difficulty in forecasting and quantifying certain significant items. These items are uncertain, depend on various factors and could have a material impact on GAAP reported results for the relevant period.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements regarding Nano’s future growth, strategic plan and value to shareholders; the Company’s expectation that the phases of the strategic plan will increase shareholder value, streamline operations, monetize product lines and progress toward potentially selecting a compelling opportunity; the Company’s expectations that it will announce additional product line monetization in the coming weeks; the Company’s expectations in the success of future strategic alternatives in reducing complexity, lowering annualized cash burn, strengthening the Company’s financial flexibility and delivering significant long term value creation in 2026 and beyond; and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano’s annual report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2026, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.
Contacts:
Investors: Purva Sanariya
Director, Investor Relations
ir@nano-di.com
Media: Samuel Manning
Principal Manager, External Communications
press@nano-di.com
|
NANO DIMENSION LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data) (Unaudited) | ||||||||
| March 31, | December 31, | |||||||
| 2026 | 2025 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 355,278 | $ | 204,672 | ||||
| Bank deposits | 8,781 | 168,997 | ||||||
| Marketable equity securities | 75,719 | 84,154 | ||||||
| Restricted bank deposits | 594 | 123 | ||||||
| Trade receivables, net of allowance for doubtful accounts ($939 and $861, respectively) | 22,700 | 26,047 | ||||||
| Inventory | 31,703 | 32,878 | ||||||
| Other current assets | 10,622 | 8,938 | ||||||
| Total current assets | 505,397 | 525,809 | ||||||
| Restricted bank deposits | 1,254 | 1,610 | ||||||
| Property, plant and equipment, net | 23,621 | 24,840 | ||||||
| Operating lease right-of-use assets | 22,487 | 23,789 | ||||||
| Deferred tax assets | 424 | 424 | ||||||
| Goodwill | — | 40,388 | ||||||
| Intangible assets, net | 18,313 | 19,434 | ||||||
| Other assets | 1,711 | 1,930 | ||||||
| Total assets | $ | 573,207 | $ | 638,224 | ||||
| Liabilities and Equity | ||||||||
| Current liabilities: | ||||||||
| Trade payables | $ | 12,974 | $ | 11,999 | ||||
| Accrued liabilities | 21,083 | 19,514 | ||||||
| Deferred revenue | 13,250 | 11,873 | ||||||
| Current portion of lease liability | 8,604 | 8,923 | ||||||
| Current portion of bank loan | 156 | 158 | ||||||
| Total current liabilities | 56,067 | 52,467 | ||||||
| Employee benefits | 3,666 | 3,697 | ||||||
| Operating lease right-of-use liabilities | 21,563 | 23,323 | ||||||
| Bank loan | 117 | 158 | ||||||
| Long-term settlement payable | 3,124 | 2,974 | ||||||
| Long-term deferred revenue | 3,226 | 3,617 | ||||||
| Total liabilities | 87,763 | 86,236 | ||||||
| Commitments and contingencies | ||||||||
| Equity: | ||||||||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 207,986,287 and 206,811,875 shares outstanding as of March 31, 2026 and December 31, 2025, respectively, and 280,480,934 and 279,306,522 shares issued as of March 31, 2026 and December 31, 2025, respectively. | 418,969 | 417,084 | ||||||
| Additional paid-in capital | 1,298,363 | 1,297,323 | ||||||
| Treasury stock | (192,507 | ) | (192,507 | ) | ||||
| Accumulated other comprehensive income | 1,241 | 1,048 | ||||||
| Accumulated loss | (1,040,622 | ) | (970,960 | ) | ||||
| Total equity | 485,444 | 551,988 | ||||||
| Total liabilities and equity | $ | 573,207 | $ | 638,224 | ||||
| NANO DIMENSION LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) | ||||||||
| Three months ended March 31, | ||||||||
| 2026(1) | 2025 | |||||||
| Revenue: | ||||||||
| Product | $ | 22,931 | $ | 11,679 | ||||
| Service | 6,794 | 2,722 | ||||||
| Total revenue | 29,725 | 14,401 | ||||||
| Cost of revenue: | ||||||||
| Product | 14,222 | 7,081 | ||||||
| Service | 3,376 | 1,479 | ||||||
| Total cost of revenue | 17,598 | 8,560 | ||||||
| Gross profit | 12,127 | 5,841 | ||||||
| Operating expenses: | ||||||||
| Research and development | 8,204 | 5,944 | ||||||
| Sales and marketing | 9,692 | 5,644 | ||||||
| General and administrative | 15,209 | 5,667 | ||||||
| Restructuring | 3,127 | 1,180 | ||||||
| Desktop Metal litigation | — | 28,069 | ||||||
| Impairment losses | 40,388 | 1,229 | ||||||
| Operating loss | (64,493 | ) | (41,892 | ) | ||||
| (Loss) gain on investment in marketable equity securities | (8,435 | ) | 8,726 | |||||
| Finance income | 3,512 | 9,320 | ||||||
| Finance expense | (246 | ) | (1,679 | ) | ||||
| Loss before income taxes | (69,662 | ) | (25,525 | ) | ||||
| Income tax expense | — | (23 | ) | |||||
| Net loss | (69,662 | ) | (25,548 | ) | ||||
| Less: Net loss attributable to non-controlling interests | — | (236 | ) | |||||
| Net loss attributable to common shareholders | $ | (69,662 | ) | $ | (25,312 | ) | ||
| Net loss attributable to common shareholders: | ||||||||
| Basic and diluted | $ | (0.34 | ) | $ | (0.12 | ) | ||
| Weighted average common shares outstanding, basic and diluted | 207,504 | 216,462 | ||||||
| Net loss | $ | (69,662 | ) | $ | (25,548 | ) | ||
| Other comprehensive income: | ||||||||
| Foreign currency translation adjustment | 193 | 593 | ||||||
| Comprehensive loss | (69,469 | ) | (24,955 | ) | ||||
| Less: Comprehensive loss attributable to non-controlling interests | — | (224 | ) | |||||
| Comprehensive loss attributable to common shareholders | $ | (69,469 | ) | $ | (24,731 | ) | ||
|
(1) The results for the three months ended March 31, 2026 include the consolidation of Markforged revenue of $17.1 million, gross profit of $6.0 million, and GAAP net loss of $50.1 million. | ||||||||
| NANO DIMENSION LTD. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) | ||||||||
| For the Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Cash flow from operating activities | ||||||||
| Net loss | $ | (69,662 | ) | $ | (25,548 | ) | ||
| Adjustments: | ||||||||
| Depreciation, amortization and non-cash lease interest | 3,701 | 574 | ||||||
| Impairment losses | 40,388 | 1,229 | ||||||
| Changes in fair value of equity securities | 8,435 | (8,726 | ) | |||||
| Share-based compensation expense | 2,925 | (786 | ) | |||||
| Changes in assets and liabilities: | ||||||||
| (Increase) decrease in inventory | 425 | 340 | ||||||
| (Increase) in other current assets | (1,500 | ) | (371 | ) | ||||
| Decrease (increase) in trade receivables | 3,258 | (2,881 | ) | |||||
| Increase (decrease)in other payables | 1,609 | (4,026 | ) | |||||
| (Decrease) increase in employee benefits | (20 | ) | 38 | |||||
| Increase in trade payables | 1,019 | 26,362 | ||||||
| Other | 2,343 | 6,316 | ||||||
| Net cash used in operating activities | (7,079 | ) | (7,479 | ) | ||||
| Cash flow relating to investing activities | ||||||||
| Change in bank deposits | 157,651 | 177,395 | ||||||
| Purchase of property plant and equipment | (167 | ) | (295 | ) | ||||
| Net cash from investing activities | 157,484 | 177,100 | ||||||
| Cash flow relating to financing activities | ||||||||
| Repayment long-term bank debt | (41 | ) | (35 | ) | ||||
| Net cash used in financing activities | (41 | ) | (35 | ) | ||||
| Increase in cash, cash equivalents and restricted cash | 150,364 | 169,586 | ||||||
| Effect of exchange rate fluctuations on cash | 357 | 204 | ||||||
| Cash, cash equivalents and restricted cash at beginning of the period | 206,405 | 318,474 | ||||||
| Cash, cash equivalents and restricted cash at end of the period | $ | 357,126 | $ | 488,264 | ||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash and cash equivalents | $ | 355,278 | 487,438 | |||||
| Restricted cash in restricted deposits, current | 594 | 60 | ||||||
| Restricted cash in restricted deposits, non-current | 1,254 | 766 | ||||||
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | $ | 357,126 | $ | 488,264 | ||||
| Non-cash operating and investing activity | ||||||||
| Lease liabilities arising from obtaining right-of-use assets | — | 119 | ||||||
| Supplemental disclosure of cash flow information | ||||||||
| Income taxes paid during the year | — | 60 | ||||||
|
NANO DIMENSION LTD. RECONCILIATION OF US GAAP TO NON-GAAP MEASURES (In thousands) (Unaudited) | ||||||||
| |
Three Months Ended March 31, |
|||||||
| | 2026 | 2025 | ||||||
| GAAP Net loss | | $ | (69,662 | ) | $ | (25,548 | ) | |
| Tax expense | | — | 23 | |||||
| Depreciation and amortization | 2,432 | 574 | ||||||
| Interest expense | 221 | — | ||||||
| Interest income | (3,652 | ) | (9,309 | ) | ||||
| Non-GAAP EBITDA (loss) | (70,661 | ) | (34,260 | ) | ||||
| Finance expenses (income) from revaluation of assets and liabilities | 8,434 | (8,726 | ) | |||||
| Exchange rate differences | 140 | 1,639 | ||||||
| Share-based payments expense | 2,925 | (786 | ) | |||||
| Desktop Metal litigation related expenses | — | 28,069 | ||||||
| Desktop Metal and Markforged transaction related expenses | 556 | 1,515 | ||||||
| Restructuring costs | 3,127 | 1,180 | ||||||
| Impairment losses | 40,388 | 1,229 | ||||||
| Acquisition inventory step-up amortization | 616 | — | ||||||
| Litigation, settlements, and contingencies | 1,951 | — | ||||||
| Non-GAAP Adjusted EBITDA | | $ | (12,524 | ) | $ | (10,140 | ) | |
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP Cost of Revenue | | 2026 | 2025 | |||||
| GAAP Cost of revenue | | $ | 17,598 | $ | 8,560 | |||
| Share-based payments expense | | 158 | 246 | |||||
| Depreciation and amortization | 739 | 142 | ||||||
| Acquisition inventory step-up amortization | 616 | — | ||||||
| Non-GAAP Cost of revenue | $ | 16,085 | $ | 8,172 | ||||
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP Gross Profit | | 2026 | 2025 | |||||
| GAAP Gross profit | | $ | 12,127 | $ | 5,841 | |||
| Share-based payments expense | | 158 | 246 | |||||
| Depreciation and amortization | 739 | 142 | ||||||
| Acquisition inventory step-up amortization | 616 | — | ||||||
| Non-GAAP Gross profit | $ | 13,640 | $ | 6,229 | ||||
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP Research and Development Expenses | | 2026 | 2025 | |||||
| GAAP Research and development expenses | | $ | 8,204 | $ | 5,944 | |||
| Share-based payments expense | | 478 | 69 | |||||
| Depreciation and amortization | 404 | 209 | ||||||
| Non-GAAP Research and development expenses | $ | 7,322 | $ | 5,666 | ||||
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP Sales and Marketing Expenses | | 2026 | 2025 | |||||
| GAAP Sales and marketing expenses | | $ | 9,692 | $ | 5,644 | |||
| Share-based payments expense | | 200 | 323 | |||||
| Depreciation and amortization | 904 | 43 | ||||||
| Non-GAAP Sales and marketing expenses | $ | 8,588 | $ | 5,278 | ||||
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP General and Administrative Expenses | | 2026 | 2025 | |||||
| GAAP General and administrative expenses | | $ | 15,209 | $ | 5,667 | |||
| Share-based payments expense | | 2,089 | (1,424 | ) | ||||
| Depreciation and amortization | 386 | 180 | ||||||
| Desktop Metal and Markforged transaction related expenses | 556 | 1,515 | ||||||
| Litigation, settlements, and contingencies | 1,951 | — | ||||||
| Non-GAAP General and administrative expenses | $ | 10,227 | $ | 5,396 | ||||
| |
Three Months Ended March 31, |
|||||||
| Non-GAAP Operating Loss | | 2026 | 2025 | |||||
| GAAP Operating loss | | $ | (64,493 | ) | $ | (41,892 | ) | |
| Share-based payments expense | | 2,925 | (786 | ) | ||||
| Depreciation and amortization | 2,433 | 574 | ||||||
| Desktop Metal litigation related expenses | — | 28,069 | ||||||
| Desktop Metal and Markforged transaction related expenses | 556 | 1,515 | ||||||
| Restructuring costs | 3,127 | 1,180 | ||||||
| Impairment losses | 40,388 | 1,229 | ||||||
| Acquisition inventory step-up amortization | 616 | — | ||||||
| Litigation, settlements, and contingencies | 1,951 | — | ||||||
| Non-GAAP Operating loss | $ | (12,497 | ) | $ | (10,111 | ) | ||
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.